Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

US Patent 9944918 · Granted Apr 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Viral gene therapy as treatment for cholesterol storage disease or disorder2025
Viral gene therapy as treatment for cholesterol storage disease or disorder2025
Codon-optimized human NPC1 genes for the treatment of Niemann-Pick type C1 defic2024
Codon-optimized human NPC1 genes for the treatment of Niemann-Pick type C1 defic2024
Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinem2022
AAV with unique capsid protein VP1 and methods of using for treatment2022
AAV with unique capsid protein VP1 and methods of using for treatment2022
Biomarkers of organic acidemias2022
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class meth2021
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class meth2021
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class meth2019
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class meth2019